11817

    532637

    MANGALAM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MANGALAM DRUG & CHEM LTD Share Price Today

    MANGALAM DRUG & CHEM LTD is currently trading at ₹27.75, up by ₹0.48 from the previous close. The stock touched an intraday high of ₹28.59 and a low of ₹27.30 during the latest trading session. Over the past one year, MANGALAM DRUG & CHEM LTD has delivered a loss of 68.82%, while the stock has declined 1.94% in the last one month.

    MANGALAM DRUG & CHEM LTD performance

    Today’s low Today’s high
    ₹ 27.30 ₹ 28.59
    ₹ 27.75
    52 week low 52 week high
    ₹ 22.80 ₹ 95.00
    ₹ 27.75
    Open Price ₹ 27.99
    Prev. Close ₹ 27.26
    Volume (Shares) 39870.00
    Total traded value ₹ 11.06
    Upper Circuit ₹ 28.62
    Lower Circuit ₹ 25.90
    info

    Investment Returns

    Over 1 Month -1.94% Over 3 Months -11.45% Over 6 Months -31.66% Over 1 Year -68.82%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MANGALAM DRUG & CHEM LTD fundamentals


    • Market cap (Cr) 43.90
    • P/E Ratio (TTM) -1.01
    • Beta 0.65
    • Book Value / share 65.27
    • Return on equity 4.76%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -13.06
    info icon alternate text
    • Market cap (Cr) 44.30
    • P/E Ratio (TTM) -1.01
    • Beta 0.57
    • Book Value / share 65.27
    • Return on equity 4.76%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -13.06
    info icon alternate text

    MANGALAM DRUG & CHEM LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 67.29
    Operating Expense 80.28
    Net Profit -13.06
    Net Profit Margin (%) -19.40
    Earnings Per Share (EPS) -8.25
    EBITDA -5.27
    Effective Tax Rate (%) -1.16
    Particulars DEC 2025 (Values in Cr)
    Revenue 58.38
    Operating Expense 68.36
    Net Profit -9.78
    Net Profit Margin (%) -16.75
    Earnings Per Share (EPS) -6.18
    EBITDA -1.35
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 49.26
    Operating Expense 61.94
    Net Profit -7.25
    Net Profit Margin (%) -14.71
    Earnings Per Share (EPS) -4.58
    EBITDA -2.80
    Effective Tax Rate (%) 41.39
    Particulars JUN 2025 (Values in Cr)
    Revenue 57.21
    Operating Expense 70.27
    Net Profit -13.73
    Net Profit Margin (%) -23.99
    Earnings Per Share (EPS) -8.67
    EBITDA -4.51
    Effective Tax Rate (%) -6.18
    Particulars MAR 2025 (Values in Cr)
    Revenue 72.78
    Operating Expense 71.52
    Net Profit 0.15
    Net Profit Margin (%) 0.20
    Earnings Per Share (EPS) 0.10
    EBITDA 10.37
    Effective Tax Rate (%) 91.32
    Particulars MAR 2026 (Values in Cr)
    Revenue 232.13
    Operating Expense 280.89
    Net Profit -43.81
    Net Profit Margin (%) -18.87
    Earnings Per Share (EPS) -27.68
    EBITDA -13.94
    Effective Tax Rate (%) 8.68
    Particulars MAR 2025 (Values in Cr)
    Revenue 317.58
    Operating Expense 313.74
    Net Profit 6.92
    Net Profit Margin (%) 2.17
    Earnings Per Share (EPS) 4.37
    EBITDA 36.30
    Effective Tax Rate (%) -38.67
    Particulars MAR 2024 (Values in Cr)
    Revenue 367.35
    Operating Expense 379.75
    Net Profit -9.05
    Net Profit Margin (%) -2.46
    Earnings Per Share (EPS) -5.72
    EBITDA 17.49
    Effective Tax Rate (%) 18.17
    Particulars MAR 2023 (Values in Cr)
    Revenue 370.20
    Operating Expense 370.47
    Net Profit 1.27
    Net Profit Margin (%) 0.34
    Earnings Per Share (EPS) 0.80
    EBITDA 26.16
    Effective Tax Rate (%) 42.53
    Particulars MAR 2022 (Values in Cr)
    Revenue 450.86
    Operating Expense 423.42
    Net Profit 19.66
    Net Profit Margin (%) 4.36
    Earnings Per Share (EPS) 12.42
    EBITDA 49.14
    Effective Tax Rate (%) 29.13
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 89.65
    ROE % 4.84
    ROCE % 8.07
    Total Debt to Total Equity 0.73
    EBITDA Margin 11.41
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 85.79
    ROE % -6.68
    ROCE % 1.16
    Total Debt to Total Equity 0.79
    EBITDA Margin 4.75
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 93.92
    ROE % 4.76
    ROCE % 7.94
    Total Debt to Total Equity 0.70
    EBITDA Margin 11.41
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 89.93
    ROE % -6.15
    ROCE % 1.15
    Total Debt to Total Equity 0.66
    EBITDA Margin 4.75
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 96.00
    ROE % 0.84
    ROCE % 6.25
    Total Debt to Total Equity 0.58
    EBITDA Margin 7.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 95.12
    ROE % 13.98
    ROCE % 17.57
    Total Debt to Total Equity 0.56
    EBITDA Margin 10.89
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 82.63
    ROE % 23.83
    ROCE % 27.41
    Total Debt to Total Equity 0.52
    EBITDA Margin 15.27
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.58
    Total Assets 366.42
    Total Liabilities 366.42
    Total Equity 148.97
    Share Outstanding 1
    Price to Book Ratio 0.79
    Return on Assets (%) 1.83
    Return on Capital (%) 2.92
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.18
    Total Assets 333.70
    Total Liabilities 333.70
    Total Equity 135.79
    Share Outstanding 1
    Price to Book Ratio 1.03
    Return on Assets (%) -2.71
    Return on Capital (%) -4.05
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.57
    Total Assets 359.23
    Total Liabilities 359.23
    Total Equity 148.65
    Share Outstanding 1
    Price to Book Ratio 0.79
    Return on Assets (%) 1.92
    Return on Capital (%) 3.01
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.00
    Total Assets 357.14
    Total Liabilities 357.14
    Total Equity 142.34
    Share Outstanding 1
    Price to Book Ratio 1.03
    Return on Assets (%) -2.53
    Return on Capital (%) -3.93
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.04
    Total Assets 357.98
    Total Liabilities 357.98
    Total Equity 151.95
    Share Outstanding 1
    Price to Book Ratio 1.02
    Return on Assets (%) 0.35
    Return on Capital (%) 0.58
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.95
    Total Assets 328.42
    Total Liabilities 328.42
    Total Equity 150.56
    Share Outstanding 1
    Price to Book Ratio 1.08
    Return on Assets (%) 5.98
    Return on Capital (%) 8.82
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.59
    Total Assets 264.10
    Total Liabilities 264.10
    Total Equity 130.78
    Share Outstanding 1
    Price to Book Ratio 1.20
    Return on Assets (%) 10.59
    Return on Capital (%) 14.81
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.78
    Cash from Operations 42.67
    Cash from Investing -19.47
    Cash from Financing -21.71
    Net change in Cash 1.40
    Free Cash Flow 62.87
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.97
    Cash from Operations 4.00
    Cash from Investing -11.82
    Cash from Financing 5.22
    Net change in Cash -2.68
    Free Cash Flow 15.83
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.98
    Cash from Operations 42.84
    Cash from Investing -19.47
    Cash from Financing -21.71
    Net change in Cash 1.57
    Free Cash Flow 63.04
    Particulars MAR 2024 (Values in Cr)
    Net Income -11.05
    Cash from Operations 12.35
    Cash from Investing -17.90
    Cash from Financing 5.69
    Net change in Cash -0.03
    Free Cash Flow 30.27
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.21
    Cash from Operations 38.05
    Cash from Investing -22.17
    Cash from Financing -16.82
    Net change in Cash -0.91
    Free Cash Flow 65.97
    Particulars MAR 2022 (Values in Cr)
    Net Income 27.73
    Cash from Operations 34.51
    Cash from Investing -27.32
    Cash from Financing 2.97
    Net change in Cash 1.36
    Free Cash Flow 62.18
    Particulars MAR 2021 (Values in Cr)
    Net Income 39.51
    Cash from Operations 36.81
    Cash from Investing -31.28
    Cash from Financing 2.69
    Net change in Cash -1.03
    Free Cash Flow 68.25
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    MANGALAM DRUG & CHEM LTD shareholding pattern

    Holding
    64.02%
    35.65%
    0.32%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    MANGALAM DRUG & CHEM LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    27.75 1.79 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 28.20
    • 26 Days 28.80
    • 10 Days 28.40
    • 50 Days 29.30
    • 12 Days 28.50
    • 100 Days 31.90
    • 20 Days 28.70
    • 200 Days 41.80
    27.41 PIVOT
    First Support 26.55 First Resistance 28.12 Second Support 25.84 Second Resistance 28.98 Third Support 24.98 Third Resistance 29.69
    RSI 41.20 ADX 23.81 MACD -0.31 Williams % R -74.66 Commodity Channel Index (CCI) -82.95
    Date 2026-07-10 Week 24746.00 Same Day 29268.00 Month 21754.00
    1 Year 0.65 3 Year 0.82
    Over 1 Month
    -1.94% down
    Over 1 Year
    -68.82% down
    Over 3 Months
    -11.45% down
    Over 3 Years
    -36.45% down
    Over 6 Months
    -31.66% down
    Over 5 Years
    -30.12% down

    MANGALAM DRUG & CHEM LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    21 Dec 2017 0.5 Interim 22 Dec 2017 Equity shares
    30 Aug 2005 0.0 Final 01 Sep 2005 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    21 Dec 2017 0.5 Interim 22 Dec 2017 Equity shares
    30 Aug 2005 0.0 Final 01 Sep 2005 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Mangalam Drugs and Organics Ltd?

    Answer Field

    Mangalam Drugs and Organics Ltd share price is for NSE ₹ 27.75 & for BSE ₹ 28.00 as on Jul 10 2026 03:29 PM.

    What is the Market Cap of Mangalam Drugs and Organics Ltd Share?

    Answer Field

    The market cap of Mangalam Drugs and Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 10 2026 03:29 PM.

    What is the 52 Week High and Low of Mangalam Drugs and Organics Ltd?

    Answer Field

    The 52 Week High and Low of Mangalam Drugs and Organics Ltd for NSE is ₹ 95.00 and ₹ 22.80 and for BSE is ₹ 94.40 and ₹ 22.70.

    What is 1 year return for Mangalam Drugs and Organics Ltd?

    Answer Field

    The 1 year returns on the stock has been -68.82%.

    What is the P/E Ratio of Mangalam Drugs and Organics Ltd Share?

    Answer Field

    As on Jul 10 2026 03:29 PM the price-to-earnings (PE) ratio for Mangalam Drugs and Organics Ltd share is -1.01.

    What is the PB ratio of Mangalam Drugs and Organics Ltd Share?

    Answer Field

    As on Jul 10 2026 03:29 PM, the price-to-book (PB) ratio for Mangalam Drugs and Organics Ltd share is 65.27.

    How to Buy Mangalam Drugs and Organics Ltd Share?

    Answer Field

    You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Mangalam Drugs and Organics Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Mangalam Drugs and Organics Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Mangalam Drugs and Organics Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |